HLS Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA40390B1094
CAD
4.34
0.05 (1.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryHLS Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
1.17%
-0.27%
1W
-0.46%
-0.34%
1M
-4.19%
3.68%
YTD
-9.96%
9.86%
1Y
-12.68%
29.6%
3Y
-29.89%
70.38%
5Y
-74.41%
70.06%
10Y
74.3%
152.32%
  • Stock Absolute Returns
  • S&P/TSX 60Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.36%
0%
-1.36%
6 Months
-9.77%
0%
-9.77%
1 Year
-12.68%
0%
-12.68%
2 Years
29.55%
0%
29.55%
3 Years
-29.89%
0%
-29.89%
4 Years
-66.46%
0%
-66.46%
5 Years
-74.41%
0%
-74.41%

HLS Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P/TSX 60
Risk Adjusted Returns v/s stock-summary